Early detection of cardiotoxicity is crucial for preventing long-term damage. Several methods are utilized for monitoring cardiac health in cancer patients:
1. Echocardiography: This imaging technique can detect changes in heart function, particularly a decrease in the left ventricular ejection fraction (LVEF). 2. Biomarkers: Blood tests measuring levels of troponin and natriuretic peptides can indicate myocardial injury and heart failure. 3. Electrocardiography (ECG): This test can identify arrhythmias and other electrical abnormalities in the heart. 4. Magnetic Resonance Imaging (MRI): Cardiac MRI provides detailed images of heart structures and can identify tissue damage or fibrosis.